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Physical activity monitors to enhance
amount of physical activity in older adults
– a systematic review and meta-analysis
Rasmus Tolstrup Larsen1* , Jan Christensen2,6, Carsten Bogh Juhl4,5, Henning Boje Andersen3 and
Henning Langberg1
Abstract
Background: The body of evidence related to the effect of physical activity monitor-based interventions has grown
over the recent years. However, the effect of physical activity monitor-based interventions in older adults remains
unclear and should be systematically reviewed.
Objective: The objective of this systematic review was to estimate the effect of physical activity monitor-based
interventions on physical activity behavior in participants aged 65 and above. Subsequently we explored the effect
on body mass index, physical capacity, and health-related quality of life and finally the impact of patient- and
intervention characteristics.
Methods: Searches in MEDLINE, EMBASE, SPORTDiscus, CINAHL, and CENTRAL were performed on April 26, 2018.
No publication date filters were applied. References of eligible studies were scrutinized and relevant journals were
hand-searched. Randomized controlled trials and randomized cross-over trials investigating the effect of a physical
activity monitor-based intervention on physical activity were included. Studies were included if the mean age of
the participants was above 65 years, and participants could walk independently with or without walking aids. The
Cochrane handbook was used as a template for extracting data and the RoB 2.0 tool was used to assess risk of bias.
Random-effects meta-analysis using Hedges g, were used to pool the study results. The main outcome of this study
was physical activity.
Results: Twenty-one studies with 2783 participants were included. The median participant age in the studies was
70.5 years, the median percentage of male participants was 42%, and the median baseline daily step count was
5268. Physical activity monitor-based interventions had a moderate effect (SMD = 0.54, 95% CI: 0.34 to 0.73)
compared to control interventions, corresponding to an average increase of 1297 steps per day in the intervention
groups. No impact of patient and intervention characteristics on the effect estimates were found.
Short conclusion: Low quality of evidence was found for a moderate effect of physical activity monitor-based
interventions on physical activity compared with control interventions. More studies with higher research methodology
standards are required.
PROSPERO registration: CRD42018083648.
Keywords: Aging, Physical activity, Older adults, Physical activity monitors, Technology, Motivation, Systematic review,
Meta-analysis, Walking, Moderate to vigorous physical activity
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Background
Physical inactivity is a growing worldwide problem and
it has been reported to cause 9% of all premature death
[1]. The amount of daily physical activity (PA) decreases
with age [2–5] and one in eight European adults age 55
or older never or hardly ever, engage in moderate to vig-
orous PA (MVPA) [6]. Functional decline is expected
and unavoidable in older adults, but regular exercise can
minimize the physiological effects of an otherwise seden-
tary lifestyle and thus increase life expectancy by im-
proving function of daily living and by slowing
progression of disease and disability [7].
An older systematic review reported that physical ac-
tivity monitor (PAM)-based interventions significantly
enhanced the amount of PA with an average of 2491
steps per day, compared to the control group interven-
tions, in adults [8]. Among older adults, the use of
PAMs has been reported to be feasible [9, 10] and sev-
eral recently published randomized controlled trials
(RCTs) report promising results [11–16]. However, these
studies differ with respect to sample characteristics,
intervention length and setting, which might have re-
sulted in the differences in the reported effect sizes be-
tween studies [11–16].
The body of evidence related to the effect of
PAM-based interventions has grown over the recent
years. However, the effect of PAM-based interventions
in older adults remains unclear and should be systematic-
ally reviewed. Further, patient and intervention character-
istics should be explored to understand their impact on
PA levels. This information may be used to inform future
research and provide guidance to clinical decision-makers
considering the use PAMs in PA programs.
Objective
The objective of this systematic review and meta-analysis
was to estimate the effect of PAM-based interventions on
amount of PA (e.g. daily step count) in participants aged
65 and above. Subsequently we aimed to explore the effect
on time spent sedentary, MVPA time, physical capacity
(e.g. measured by a cardiopulmonary exercise test or as a
walking test), body mass index (BMI), and health-related
quality of life (HRQoL) (e.g. by questionnaires). Finally, we
sought to investigate the impact of participant- (e.g. diag-
noses, age and sex distribution), intervention- (e.g. inter-
vention length, type of PA measure and feedback




This systematic review and meta-analysis is detailed ac-
cording to the recommendations of the Cochrane Hand-
book [17] and it is reported according to the PRISMA
statement. The method is described in the published re-
view protocol as well as in the PROSPERO registration
(CRD42018083648) [18, 19]. Unless otherwise stated, the
methods used and reported in this systematic review
followed the review protocol.
Eligibility criteria
We included RCTs and randomized cross-over trials
comparing any PAM-based intervention where the par-
ticipants of the intervention group received any kind of
feedback on their physical activity level measured by
PAMs, and where the control intervention did not re-
ceive feedback from the PAMs. The mean age of the
participants should be above 65 years, and participants
should be able to walk independently with or without
walking aids.
The primary outcome was PA. If more than one type
of PA measure were reported, we extracted or calculated
it in the following order: daily number of steps, daily
number of meters walked, daily amount of energy ex-
penditure (calories), daily metabolic equivalent of task
(minutes or hours) and finally, if no objective measure
was available, self-reported PA. The secondary outcomes
included:
 Time spent as sedentary (measured objectively by
PAMs)
 Time spent in MVPA (measured objectively by
PAMs or secondly as self-reported behavior)
 Physical capacity (measured by a cardiopulmonary
exercise test or secondly as a walking test)
 BMI
 Self- reported HRQoL determined by questionnaires.
End-point scores were used to calculate treatment ef-
fects. To avoid unit-of-analysis error with cross-over tri-
als, the outcome was extracted at baseline and when the
first period ended, as recommended in the Cochrane
Handbook chapter 16.4.5 [20]. Reported adverse events
or withdrawals due to illness were extracted if possible.
Information sources
Preliminary searches and identification of relevant pa-
pers were performed to identify relevant search terms
and subject headings. The final systematic search for eli-
gible studies in MEDLINE, EMBASE, SPORTDiscus,
CINAHL, and CENTRAL was performed on April 26,
2018. Additional studies that met the inclusion criteria
were obtained through an independent review of article
references by two reviewers (RTL and JC). The Clinica-
trials.gov database was searched on February 13th 2018
to locate ongoing relevant studies.
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Search
The search string consisted of a combination of rele-
vant keywords and subject headings for: PAMs, older
adults, and randomized studies and can be found in
the study protocol [19]. No restrictions on language
or publication-time were applied. The authors of un-
obtainable studies or studies with missing data were
contacted to obtain missing information.
Study selection, data items and data collection process
Citations was imported into the technology platform,
Covidence. Two authors (RTL and JC) screened the titles
and abstracts independently and assessed full-text re-
ports. Any inconsistencies between authors was dis-
cussed and rectified in consultation with a third author
(CJ). Data extraction was performed independently by
two authors (RTL and JC).
Risk of bias in individual studies
Two review authors (RTL and JC) independently
assessed study quality using the Risk of Bias 2.0 tool [21]
on study outcome level. Disagreement was solved by dis-
cussion with a third reviewer (CJ).
Summary measures
Treatment effects, on continuous data, were expressed
as standardized mean differences (SMD) with 95% confi-
dence intervals. The SMD was translated back to a mean
difference in steps for the primary outcome, MVPA
time, meters on 6MWT for physical capacity and BMI
(kg/m2) respectively, using the method described by
Bliddal and Christensen [22]. The SDs used for translat-
ing the SMDs were extracted for each outcome from the
intervention group from largest study with the lowest
risk of bias, in which objectively measured values were
favored. The SDs used were 2402 steps per day [23],
16.2 min of daily MVPA [14], 80 m on a 6MWT [24]
and 4.8 kg/m2 on BMI [25]. When reported in text or
study flow diagrams, adverse event and participant with-
drawal rates were extracted and expressed as relative
risks with 95% confidence intervals. If a study reported
zero adverse events, the Der-Simonian & Laird method
was used and 0.5 was added as a value to enable random
effects meta-analysis [26].
Synthesis of results
The effect size was calculated using a random-effects
model adjusting to Hedges’ g, using end-point scores
only. In studies where no continuous data were available
for the outcomes, we used dichotomous data and con-
verted the odds ratios and the standard errors (log ES)
into the standard mean difference using the Chinn et al.
approach described in chapter 9.4.6 of the Cochrane
Handbook [27]. An alpha level of 0.05 was considered
statistically significant. Stata/IC 15.1 for Mac (64-bit
Intel), Copyright 1985–2017 StataCorp LLC was used
for all statistical analyses.
Unit of analysis issues
One study had two relevant intervention groups [11].
The intervention groups of the study were included as
two separate comparisons and the control group from
the study was separated according to guideline in the
Cochrane Handbook chapter 16.5.4 [28].
Additional analyses
The heterogeneity of the extracted results was examined
using the Cochrane Q test and quantified with I2 statis-
tic. We performed subgroup analyses to explore the im-
pact of characteristics of participants and intervention
and stratified the effect size on the following nominal
variables: type of PAM (accelerometer versus pedom-
eter), diagnoses of participants (none, cardiac patients,
COPD or osteoarthritis), feedback frequency (daily,
weekly or monthly) and overall risk of bias (low, some
concerns and high). We conducted three explorative
subgroup analyses: one analysis on control intervention
content (advice group, goal setting, maintain usual PA,
other training, rehabilitation program, and usual care),
one analysis on grouping the interventions into types
(gamification, incremental goals, monthly feedback and
reinforcement, ongoing counseling and pre-counseling),
and one analysis on active control interventions versus
non-active control interventions (maintain usual PA or
no intervention).
We chose to investigate how the method of physical ac-
tivity reporting (i.e., objective measurement, self-report,
interview) affected the results. This sensitivity analysis was
deemed more informative than the protocolled sensitivity
analysis on mean differences in daily number of steps,
daily number of meters walked, daily amount of energy
expenditure measured as calories, daily metabolic equiva-
lent of task, and self-reported physical activity.
Publication bias were assessed by Eggers test. If small
study bias was present, the Duval and Tweedie nonpara-
metric “trim and fill” analysis was conducted adjusting
the effect size [29, 30].
We performed univariate meta-regressions on con-
tinuous data on the following variables:
Age (years), sex distribution (percent), number (or per-
cent) of participants with walking aids, intervention
length (weeks), baseline PA (steps), and BMI.
Results
Study selection
Twenty-one studies were included in the review [11–16,
23–25, 31–42]. We identified one ongoing trial (Clinical-
trials.gov Identifier: NCT03086850), but we did not
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include this study as it was in the participant recruit-
ment phase. Citations and reasons for exclusion from
full text screening are listed in the Additional file 1:
Table S3. The study selection process is illustrated in
Fig. 1. A summary of the included studies is listed
in Table 1. Characteristics of the 21 included studies
(22 comparisons, 2783 participants) are listed in
Additional file 1: Table S2.
Study characteristics
Risk of bias within studies
The risk of bias summary and review authors’ judge-
ments about each risk of bias item are presented in
Fig. 2. Figure 3 illustrates the risk of bias as percentages
across all included studies for each risk of bias item.
Overall, five studies were considered as having a low risk
of bias [13, 14, 23, 25, 40], 10 studies were considered as
having some concerns [12, 15, 16, 24, 31, 34–36, 38, 39],
and six studies were considered as having a high risk of
bias [11, 12, 32, 33, 37, 41]. Judgements and support for
judgement about each item is presented for all studies in
characteristics of studies in Additional file 1.
In two studies the risk of bias assessment differed be-
tween outcomes. Kolt et al. and Nolan et al. were
assessed to have high risk of selective outcome report-
ing, on self-reported HRQoL (SF-36) [25, 31].
Synthesis of the results and effect of the interventions
Twenty studies (21 study comparisons and 2704 partici-
pants) evaluated the effect of PAM on PA. The random
effects meta-analysis is illustrated in Fig. 4. The overall
SMD was 0.54, (95% CI: 0.34 to 0.73), I2 = 79.2%, p <
0.001, favoring the PAM interventions. When using a
SD of 2402 steps per day, this corresponds to a weighted
mean difference of 1297 (95% CI: 817 to 1753) favoring
the intervention groups [23].
Secondary outcomes
Only one study (35 participants) reported the effect of
the intervention on time spent sedentary [13]. The SMD
of this study was calculated to be − 0.40 (95% CI: -1.07
to 0.27), favoring the PAM intervention. The difference
in weekly sedentary time was 44.0 min (95% CI: 37.1 to
50.9) with the control group being most sedentary.
Fig. 1 PRISMA flow diagram illustrating the inclusion process
Larsen et al. European Review of Aging and Physical Activity            (2019) 16:7 Page 4 of 13
A total of eight studies (1686 participants) reported data
on effect of the interventions on MVPA time. The overall
SMD was 0.34 (95% CI: 0.15 to 0.52), I2 = 65.8%, p =
0.005, favoring the PAM interventions. When using a SD
of 16.2 of daily MVPA, this corresponds to a weighted
mean difference of 5.5 min per day (95% CI: 2.4 to 8.4)
with more MVPA in the intervention groups [14].
A total of four studies (754 participants) reported the
effect of the intervention on physical capacity. The over-
all SMD was 0.19 (95% CI: -0.10 to 0.48), I2 = 48.8%, p =
0.118, favoring the PAM intervention. When using a SD
of 80 m, this corresponds to a weighted mean difference
on 15 m (95% CI: -8 to 38) with more meters walked on
a 6MWT in the intervention groups [24].
Table 1 Summary of the characteristics of the included studies. Citations of studies that reported results on domains are listed after
the domain
Methods Number of studies (%)
RCT with parallel group design [11–16, 23–25, 31, 32, 34–42] 20 (95%)
RCT with cross over design [33] 1 (5%)
Setting Number of studies (%)
Europe [12, 13, 23, 24, 31, 32, 35, 38] 8 (38%)
Australia and New Zealand [14, 16, 25, 37] 4 (19%)
Asia [15, 36, 40, 41] 4 (19%)
North America [11, 33, 34, 39, 42] 5 (24%)
Participant diagnoses Number of studies (%)
Osteoarthritis [23] 1 (5%)
COPD [12, 31, 36] 3 (14%)
Cardiac patients [16, 40] 2 (10%)
None [11, 13–15, 24, 25, 32–35, 37–39, 41, 42] 15 (71%)
Participant characteristics Median (range)
Median age in studies (k = 21) 70.5 (65 to 81.5)
Median body mass index in studies [11, 12, 14, 15, 23, 25, 31, 35, 36, 39, 40, 42] 27.9 (21.1 to 31.82)
Median percentage of male participants in studies [11–16, 23–25, 31, 33–36, 38–42] 42 (0 to 88)
Median percentage of married participants [13, 16, 24, 25, 32, 35, 39] 61.4 (39 to 80.5)
Median baseline daily step count [11–13, 15, 23, 31, 33–35, 39, 41] 5268 (2420 to 7697)
Intervention Median (range)
Length median weeks (k = 21) 12 (4 to 52)
Physical activity monitor Number of studies (%)
Accelerometer [12, 14, 32, 36, 41] 5 (24%)
Pedometer [11, 13, 15, 16, 23–25, 31, 33–35, 37–40, 42] 16 (76%)
Frequency of feedback Number of studies (%)
Daily [11–13, 15, 16, 23–25, 32, 33, 35, 37–42] 17 (81%)
Weekly [14, 31, 33] 3 (14%)
Monthly [36] 1 (5%)
Outcomes Number of studies (%)
Reported results on physical activity [11–16, 23–25, 31–36, 38–42] 20 (95%)
Reported results on sedentary time [13] 1 (5%)
Reported results on MVPA time [14, 24, 25, 31, 35, 41, 42] 7 (33%)
Reported results on physical capacity [24, 36, 37, 41] 4 (19%)
Reported results on health-related quality of life [13, 24, 25, 31, 36] 5 (24%)
Reported results on body mass index [25, 36] 3 (14%)
Reported results on adverse events [13, 14, 16, 24, 31, 32, 35–37, 40] 10 (48%)
RCT Randomized Controlled Trial, COPD Chronic Obstructive Pulmonary Disease, MVPA Moderate to Vigorous Physical Activity, k number of studies. The reported
median of mean values are unweighted in relation to study size or reporting precision
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A total of three studies (570 participants) reported
data for effect of the interventions on BMI. The overall
SMD was 0.15, (95% CI: -0.01 to 0.31), I2 = 0%, p =
0.752, favoring the control intervention. When using a
SD of 4.8 kg/m2, this corresponds to a mean difference
on 0.72 kg/m2 (95% CI: -0.05 to 1.50) with the control
groups having the lowest BMI [25].
A total of five studies (1038 participants) reported data
for effect of the interventions on HRQoL. The overall
SMD was 0.01, (95% CI: -0.12 to 0.14), I2 = 0.0%, p =
0.541, favoring the PAM interventions.
A summary of the analyses on the secondary outcomes
are illustrated in Fig. 5.
Meeting the study specific recommended level of physical
activity
No studies reported data on this.
Additional analyses
Subgroup analyses on the type of PAM, diagnoses, feed-
back frequency, risk of bias judgement and type of PA
measure on the effect of the intervention on PA (Add-
itional file 1: Figure S6), MVPA time (Additional file 1:
Figure S7), physical capacity (Additional file 1: Figure
S8), BMI (Additional file 1: Figure S9), and HRQoL
(Additional file 1: Figure S10) are presented in the Add-
itional file 1. No significant differences in the subgroup
analyses were observed for any outcomes.
Additional file 1: Table S3 reports data from
sensitivity-analyses (univariate meta-regressions) on how
the SMD from all outcomes sere affected by the follow-
ing variables: age in years, sex distribution in percent
male, percent of participants with walking aids, interven-
tion length in weeks, baseline PA measured in steps per
day, BMI in kg/m2. None of the above-mentioned vari-
ables were significantly correlated with the effect size for
any outcomes, nor did any variable reduce Tau2 statistic.
There were insufficient observations to analyze the cor-
relation between effect size and percent of participants
with walking aids for all outcomes.
Egger’s test showed significant small study bias for the
effect on PA (p = 0.036), indicating that the analyzes are
overestimating the effect on PA (Additional file 1: Figure
S11). The bias adjusted (trimmed and filled) analysis
with random effects revealed an adjusted SMD on 0.37,
(95% CI: 0.15 to 0.59) after filling the analysis with three
fictive studies. Analyzing the effect on time spent in
MVPA, physical capacity, BMI, and HRQoL, no small
study bias was found using Egger’s test.
Adverse events
A total of 11 studies (1927 participants) reported data for
adverse events. The overall relative risk for adverse events
was 0.91, (95% CI: 0.66 to 1.25), I2 = 0.0% p = 0.942, with
Fig. 2 Risk of bias summary: review authors’ judgements about each
risk of bias item for each included study. +: Low risk of bias,?:Some
concerns, %: High risk of bias
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Fig. 3 Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies
Fig. 4 Random effects meta-analysis with effect of the interventions on physical activity using Hedges g. N: Number of participants; SMD;
standardized mean difference. For each study, the diamond represents the standardized mean difference of the intervention effect with
the horizontal line representing 95% confidence intervals. The large diamonds represent the pooled standardized mean difference between the
intervention groups and the control groups
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more adverse events and withdrawals due to illness in the
control groups. The random effects meta-analysis for the
adverse events is shown in Additional file 1: Figure S12.
Explorative post-hoc subgroup analyses
Additional file 1: Figure S13, illustrates an explorative ana-
lysis of effect of interventions on PA sorted on type of
control intervention and Additional file 1: Figure S14, il-
lustrates an explorative analysis of effect of interventions
on PA sorted on groupings of intervention types. How-
ever, none of the findings were significant. Additional file 1:
Figure S15, illustrates an explorative analysis of effect of
interventions on PA sorted on active control interventions
versus non-active control interventions. The 11 study
comparisons (1219 participants) with non-active control
interventions had a significantly larger effect compared to
the 10 study comparisons (1485 participants) with an ac-
tive control intervention.
Discussion
The objective of this systematic review was to investigate
the effect of PAM-based interventions on older adults.
Our primary outcome of interest was PA and the main
results include a moderate effect, equivalent to a larger
increase on 1297 more steps per day in the intervention
groups and the small to moderate effect on MVPA time
equivalent to a larger increase on 8 more minutes per
day in the intervention groups. As we were not able to
explain the heterogeneity of the results with any of our
sub- or sensitivity analyses, the effect of the interven-
tions may be applicable to the broadly defined older
adult population. However, further potential influences,
such as medication and disease specific treatments need
to be considered.
In terms of translating the effect on 1297 more steps
per day, there is a lack of evidence on how much is clin-
ically relevant change in general, for older adults. The
WHO recommends that older adults are equally
physically active as their younger counterparts but if
co-morbidities limits their ability to be physically active,
they should be as active as their conditions allow [43]. A
systematic review suggests that the WHO-recommended
30min of MVPA per day is equivalent to 7000 to 10,000
steps per day in older adults [43, 44]. According to
Table 1, the median baseline daily step count in the
studies was 5268 which makes the effect on 1297 steps
equivalent to a 25% increase in daily number of steps. If
the effect size is added to the median baseline daily step
count, the average older adult will get close to 7000
steps per day. This highlights the clinical relevance of
Fig. 5 Summary of random effects meta-analyses with effect of the interventions on secondary outcomes. K: number of studies; N: Number of
participants; SMD: standardized mean difference; HRQoL: health-related quality of life. For each analysis, the diamond represents the standardized
mean difference of the pooled intervention effect with the horizontal line representing 95% confidence intervals
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the results. Other more invasive exercise interventions
may be more effective in increasing the amount of daily
PA in older adults, but as PAM based interventions are
not very invasive, they could be implemented in large
scale projects as well.
This review provides evidence for the use of PAMs as
an intervention to promote PA among older adults. Our
finding of a moderate effect is in line with a former sys-
tematic review by Bravata et al. that estimated the effect
size to be 2491 steps per day (95% CI: 1098 to 3885) in a
population with a mean age on 49 years [8]. The popula-
tion of interest in the Bravata et al. systematic review is
more than 20 years younger than the median mean age
in the included studies from this review [8]. As the level
of physical activity decrease with age [2–5], a younger
population is expected to be more active which may ex-
plain why the effect in steps per day is almost twice as
large in the Bravata et al. systematic review [8]. However,
as the effect sizes are not significantly different from
each other, the above-mentioned explanation is only
relevant if future systematic reviews find a significant ef-
fect modification from age, which we did not find in this
review.
Even though we only included one study with results
on sedentary time [13], this study was also included in a
recent published systematic review from Qui et al. that
reports PAM usage to be significantly associated with re-
duced sedentary time among adults [45].
Among older adults, level of PA is associated with,
age, BMI and sex [46]. Contrary to this we were not able
to explain the variance in the effect of the interventions
through participant age, BMI or sex. However, this also
means that we did not find any specific subgroup of
older adults that may not benefit from using PAMs to
enhance the level of physical activity.
The prevalence of frailty and chronic diseases are high
in older adults [47, 48]. At first glance, our results could
be limited to older adults with a higher function and a
lower disease prevalence as the majority of the included
studies included community dwelling older adults without
specific diseases [11, 13–15, 24, 25, 32–35, 37, 38, 41, 42].
However, among these studies, several samples were in-
active or did not meeting PA recommendations [11, 13,
32, 38]. One study was conducted in a post-acute care re-
habilitation setting [14] and other studies included pa-
tients with hypertension [24], osteoarthritis [34], cancer
[34], and other chronic diseases [35]. Four studies did not
describe the disease characteristic of the participants [15,
24, 41, 42]. The broad range of participant characteristics
across studies is a strength of this systematic review as it
increases the generalizability of the findings to the general
population.
None of the subgroup analysis showed any significant
impact of risk of bias on the effect. We did however find
an overestimation of the effect size on the PA caused by
small study bias. Publication bias will normally overesti-
mate the effect of the published interventions due to
type 1 errors or selective outcome reporting [49]. In
summary, we have chosen to downgrade the overall
quality of the evidence due to publication bias.
We conducted three additional analyses to investigate
the impact of intervention and control intervention con-
tent. PAM-based interventions had a significant greater
effect in studies with non-active control interventions
compared to studies with active control interventions.
No other effects were significant. This analysis is recom-
mended to obtain a meaningful estimate of the effect of
the interventions and to avoid a confused picture of ab-
solute intervention effects [50]. Using non-active con-
trols will by nature give a larger effect size, as most
interventions (also control interventions) will have some
effect. Thus, future studies should use direct compari-
sons to investigate if PAMs can be an effective add-on
intervention, or if other types of behavior change strat-
egies can effectively increase the effect from the PAMs.
A Hawthorne-effect, meaning that the participants in
control groups could be expected to increase their level of
PA, simply due to participation in a PA study may be
present in the included studies. This was also discussed in
the systematic review published by Bravata et al. [8].
When comparing a PAM-based intervention where the
participants receive feedback to a control group that are
aware that they are being measured, the effect size might
be slightly underestimated when compared to PAM-based
walking programs with no control groups. This has been
addressed systematically by Waters et al., who found a
similar effect in both control and intervention groups in
eight of 29 PA trials [51]. This is in line with our explora-
tive results from Additional file 1: Figure S13 that illustrates
a larger effect in studies that includes control groups who
were asked to maintain usual PA and Additional file 1: Fig-
ure S15 that illustrates a larger effect size in studies that
uses non-active control interventions. This may be ex-
plained by participants who volunteer for trials because
they wish to increase their level of PA, participants being
refractory or nonadherent after being allocated to a control
group and several other factors which should be kept in
mind when interpreting results from PA trials or reviews.
Limitations
There were some deviations from the published study
protocol [19]. Firstly, there were insufficient data to de-
termine if participants met the study-specific recom-
mendation for level of physical activity. We proposed to
study this outcome in our protocol; however, none of
the studies included in this review reported on this out-
come. Secondly, we chose to pool the moderate and vig-
orous activity as most of the included studies did not
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distinguish between these intensity categories in their
reporting.
We performed a wide and comprehensive literature
search across several relevant databases, and used a pearl
growing strategy where two reviewers independently lo-
cated relevant references through journal sites and refer-
ence lists of included studies. Additionally, we obtained
relevant references by using forward and backwards ref-
erence searches. Despite this wide and robust search
strategy, it is possible that not all relevant studies were
included in this systematic review.
In terms of translating the SMDs back to number of
steps, MVPA time, meters walked in a 6MWT and BMI,
the translation should only be read as a way of making
our results easier to interpret and comes with limitations
to generalizability. Firstly, we assume that the SMD can
be used to extrapolate results, but some studies used dif-
ferent scales and outcome measures which might bring
some problems. Secondly, the true SD of the population
is impossible to estimate. However, when choosing the
SDs from the largest study with the lowest risk of bias
rating we have tried to be transparent and avoid bias in
the selection. It should be noted that interpretation must
happen with caution as it basically only represents the
study from which the SD was chosen.
This systematic review is focused on older adults
above the age of 65 years. As reported in Table 1, some
of the studies will include results from participants
younger than 65 which might bring some bias to our ex-
ternal validity. However, according to Additional file 1:
Table S3, the association between study mean age and
the effect size was clearly not significant for all outcomes
and the study mean age explained almost no effect size
heterogeneity. We hereby acknowledge the limitation
that some included studies would have had younger par-
ticipants, but we find no evidence for affecting the exter-
nal validity to the population of interest.
Body of evidence
We found that the quality of the body of evidence of
PAM-based interventions was low to moderate. Our
results were affected by unexplained heterogeneity,
publication bias and imprecision. The pooled effects
for time spent sedentary, physical capacity, BMI and
self-reported HRQoL were not significant. Further-
more, the confidence interval for the effect size of the
primary outcome, PA, suggests that the overall effect
is small to moderate. However, a moderate quality of
evidence was found on the risk of adverse events be-
ing the same in the intervention and the control
groups. PAMs seem useful for public health interven-
tions as it seems to be safe and effective to include
them in PA programs for old adults. The grading of
the body of evidence for each outcome is reported in
the summary of findings table (Additional file 2).
Conclusion
General interpretation of results
This review demonstrates low quality of evidence for a
moderate effect on PA, equivalent to a larger increase at
1297 more steps per day, when comparing PAM-based in-
terventions with control interventions in 21 studies. Fur-
thermore, this review demonstrates moderate quality of
evidence for a small to moderate effect on MVPA time
equivalent to 8 more minutes per day. This review did not
find an effect on physical capacity, BMI or HRQoL. Given
the heterogeneity of the study samples, the results are likely
to be applicable to a broad older population, but medica-
tion and disease specific treatments need to be considered.
Implications for future practice and research
It seems safe and feasible to use PAMs in PA interven-
tions in older adults. To avoid publication bias and un-
explained heterogeneity, more randomized studies with
high methodological quality and large sample sizes, are
needed to determine possible participant characteristics
associated with the adherence to and effect of the inter-
ventions. Furthermore, future studies should investigate
if PAMs should be included as add-on interventions, or
if other types of behavior change strategies should be ap-
plied to PAM-based interventions. The evolution of
Internet of Things in medicine will emerge and have a
great impact on how clinical decision making, preventive
medicine and rehabilitation will take place in the future
[52, 53]. To ensure that the costs and expenses are used
correctly, it seems highly important to have ongoing
reviewing of the literature and to include recent pub-
lished RCTs in updated version of systematic reviews in
this area of behavioral intervention research.
Summary box (bullets)
 PAM-based interventions seem to be safe and
effective in enhancing the level of PA in older
adults.
 Low quality of evidence exists for PAM-based
interventions having a moderate effect on PA,
equivalent to 1297 more steps per day.
 Moderate quality of evidence exists for PAM-based
interventions having a small to moderate effect on
MVPA time equivalent to 8 more minutes per day.
 This review could not demonstrate an effect of PAM
intervention on physical capacity, BMI or HRQoL.
 Future studies should not use non-active control
interventions but instead compare PAM-based
interventions with other active interventions or
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conduct add-on designs to investigate if the effect
size of the PAM-intervention can be increased.
Additional files
Additional file 1: Figure S6. Subgroup analysis on effect of the
interventions on physical activity sorted on type of physical activity
monitor, diagnoses, feedback frequency, risk of bias judgement and type
of physical activity measure. Results are from random effects model using
Hedges g. K: Number of studies; SMD: standardized mean difference;
PAM: physical activity monitor; COPD: chronic obstructive pulmonary
disease. For each analysis, the diamond represents the standardized
mean difference of the pooled intervention effect with the horizontal line
representing 95% confidence intervals. Figure S7. Subgroup analysis on
effect of the interventions on moderate to vigorous physical activity,
sorted on type of physical activity monitor, diagnoses, feedback
frequency, and risk of bias judgement. Results are from random effects
model using Hedges g. K: Number of studies; SMD: standardized mean
difference; PAM: physical activity monitor; COPD: chronic obstructive
pulmonary disease. For each analysis, the diamond represents the
standardized mean difference of the pooled intervention effect with the
horizontal line representing 95% confidence intervals. Figure S8.
Subgroup analysis on effect of the interventions on physical capacity,
sorted on type of physical activity monitor, diagnoses, feedback
frequency, and risk of bias judgement. Results are from random effects
model using Hedges g. K: Number of studies; SMD: standardized mean
difference; PAM: physical activity monitor; COPD: chronic obstructive
pulmonary disease. For each analysis, the diamond represents the
standardized mean difference of the pooled intervention effect with the
horizontal line representing 95% confidence intervals. Figure S9.
Subgroup analysis on effect of the interventions on body mass index,
sorted on type of physical activity monitor, diagnoses, feedback
frequency, and risk of bias judgement. Results are from random effects
model using Hedges g. K: Number of studies; SMD: standardized mean
difference; PAM: physical activity monitor; COPD: chronic obstructive
pulmonary disease. For each analysis, the diamond represents the
standardized mean difference of the pooled intervention effect with the
horizontal line representing 95% confidence intervals. Figure S10.
Subgroup analysis on effect of the interventions on health-related qualify
of life, sorted on type of physical activity monitor, diagnoses, feedback
frequency, and risk of bias judgement. Results are from random effects
model using Hedges g. K: Number of studies; SMD: standardized mean
difference; PAM: physical activity monitor; COPD: chronic obstructive
pulmonary disease; HRQoL: Health-related quality of life. For each
analysis, the diamond represents the standardized mean difference of the
pooled intervention effect with the horizontal line representing 95%
confidence intervals. Positive values favor the intervention. Figure S11.
Funnel plot with Eggers line illustrating risk of publication bias in the
analysis of effect of the interventions on physical activity. SMD:
standardized mean difference. Figure S12. Random effects meta-analysis
on withdrawals due to illness and adverse events. For each study, the
diamond represents the specific relative risk of withdrawing with the
horizontal line representing 95% confidence intervals. Results are from
random effects model with relative risks. RR: Relative risk. The large
diamond represents the pooled relative risk. Values below one equals
more events in the intervention groups. Figure S13. Explorative
subgroup analyses of effect of interventions on physical activity sorted on
control intervention. For each study, the diamond represents the
standardized mean difference of the intervention effect with the
horizontal line representing 95% confidence intervals. Results are from
random effects model using standardized mean difference (SMD)
adjusted to Hedges g. PA: physical activity. The large diamonds represent
the pooled standardized mean difference between the intervention
groups and the control groups. Positive values favor the intervention.
Figure S14. Explorative subgroup analyses of effect of interventions on
physical activity sorted on additional intervention content. Results are
from random effects model using standardized mean difference (SMD)
adjusted to Hedges g. For each study, the diamond represents the
standardized mean difference of the intervention effect with the
horizontal line representing 95% confidence intervals. The large diamonds
represent the pooled standardized mean difference between the
intervention groups and the control groups. Positive values favor the
intervention. Figure S15. Figure S15. Explorative subgroup analyses of
effect of interventions on physical activity sorted on active control
intervention or non-active control intervention. Results are from random
effects model using standardized mean difference (SMD) adjusted to
Hedges g. For each study, the diamond represents the standardized
mean difference of the intervention effect with the horizontal line
representing 95% confidence intervals. The large diamonds represent the
pooled standardized mean difference between the intervention groups
and the control groups. Table S1. Characteristics of included studies.
Table S2. Univariate meta-regressions between standardized mean
differences from all outcomes and age, gender distribution, number of
participants with walking aids, intervention length, baseline physical
activity and body mass index. Table S3. Citations and reasons for
exclusion from full text screening. (DOCX 4040 kb)
Additional file 2: Summary of findings table. (DOCX 17 kb)
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